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The complete nucleic acid sequence of human preproapolipoprotein (apo) C-II has been determined from 
2 apoC-II clones isolated from 2 different human genomic DNA libraries. The cloned fragments were ap- 
prox. 14 and 18 kb long, and sequence analysis established that the apoC-II gene consists of 3338 nucleotides 
containing 3 intervening sequences of 2391, 167, and 298 bases. The first intron is located within the 5’- 
untranslated region of apoC-II and contains 4 Alu type sequences. The second intron interrupts the codon 
specifying amino acid - 11 of the apoC-II signal peptide. The last intron, which contains a 38 bp sequence 
which is repeated 6 times, interrupts the codon specifying for amino acid +44 of the mature apolipoprotein. 
Preproapolipoprotein C-II; Genomic sequence; Oligonucleotide probe; Lipoprotein metabolism 
1. INTRODUCTION 
Human apolipoprotein C-II plays a central role 
in lipid metabolism as a cofactor for lipoprotein 
lipase, the enzyme that hydrolyzes triglycerides in 
plasma chylomicrons and very low density lipopro- 
tein [l-3]. The amino acid sequence of human 
apoC-II has been previously reported by our 
laboratory [4]. The major plasma isoform of 
apoC-II is a proprotein composed of a single 
polypeptide chain of 79 amino acids which then 
undergoes proteolytic cleavage to form the mature 
73 amino acid apolipoprotein [5]. Synthetic 
oligonucleotides based on this amino acid sequence 
enabled us to isolate an apoC-II clone from the 
cDNA libraries. Nucleic acid sequence analyses of 
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human apoC-II cDNA clones revealed that the 
apoC-II mRNA encodes a 101 amino acid long 
apolipoprotein which includes a 22 amino acid 
signal peptide and a 79 amino acid residue plasma 
apolipoprotein [6-g]. By utilizing human-mouse 
somatic cell hybrids we have localized the apoC-II 
gene to chromosome 19 [lo]. Southern blot 
analyses of DNA of patients with familial apoC-II 
deficiency have thus far revealed no major inser- 
tions or deletions in the apoC-II gene [l 1,121. 
However, the deficiency of apoC-II in the plasma 
of these kindreds may be due to either minor muta- 
tions in the structural or regulatory regions of the 
apoC-II gene or to a derangement in post- 
transcriptional processes. 
In order to better understand the biosynthesis 
and processing of apoC-II in both normal and 
diseased states, we have cloned the gene for normal 
human apoC-II. In this report, we present the 
complete nucleic acid sequence and genomic 
organization of the preproapoc-II gene as deter- 
mined from 2 different libraries and compare it 
with the previously published sequence of Wei et 
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al. [ 131. We believe this work will provide the basis 
for understanding the underlying defects in pa- 
tients with apoC-II deficiency. 
2. MATERIALS AND METHODS 
2.1. Cloning and screening of genomic libraries 
for apoC-II clones 
A human placental genomic DNA phage library 
was a generous gift of Dr Philip Leder. A second 
library was made by ligating the 15-20 kb size 
DNA obtained by a partial Mb01 digest of normal 
human white blood cells with EMBL3 vector 
DNA. E. co& P2392 was then infected with the 
EMBL3 recombin~t phage. Screening of both 
libraries was performed as described [14]. 
2.2. Large scale preparation of phage DNA and 
subcloning into pBR322 
Large scale preparations of phage DNA were 
performed as described by Maniatis et al. [15] with 
minor modifications 1141. 5 kb BamHI and 3.7 kb 
EcoRI fragments of insert genomic DNA isolated 
from the phage containing the apoC-II insert were 
purified by agarose gel electrophoresis and inserted 
into the BafrrHI and EcoRI sites of pBR322. 
R~ombin~t clones were selected by testing for 
antibiotic resistance and hybridization to the 
apoC-II cDNA probe. Plasmid DNA was isolated 
as described [6]. 
Restriction endonucleases were purchased from 
New England Biolabs or Bethesda Research 
Laboratories. Reactions were performed under the 
conditions specified by the suppliers. 
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2.3. DNA sequencing and primer extension of 
apoC-II mRNA 
DNA fragments were end labelled as reported 
]6] and sequenced by the chemical cleavage method 
of Maxam and Gilbert 1161 or the dideox- 
ynucleotide chain termination method of Sanger et 
al. [ 171 following subcloning into the Ml3 vectors 
mp18 and mp19. 
A 30 base-long synthetic oligonucleotide com- 
plementary to amino acid residues - 9 to + 1 (Val- 
Gin-Gly-Thr-Gln-Gln-Pro-Gln-Gln-Asp) of apoC- 
II was obtained from OCS Laboratories and used 
as a primer for 5 ‘-extension of apoC-II mRNA. 
24 ng of primer and 15 pg of human liver 
polyadenylated RNA were utilized for 5 ’ -exten- 
sion by the method described in [ 181. The extended 
product was sequenced by the Maxam and Gilbert 
procedure [16] and then analyzed on 8% urea 
polyacrylamide sequencing els. 
3. RESULTS AND DISCUSSION 
Eight apoC-II genomic clones were identified by 
screening 1.5 x lo6 phage from each library with 
the apoC-II cDNA probe. Two clones were grown 
in large scale and analyzed following restriction en- 
donuclease digestion by Southern blot. These 
clones contained a 14 and an 18 kb fragment of 
human genomic DNA inserted into the BamHI 
cloning site of Charon 28 and EMBL3, respective- 
ly. A 5 kb BamHI and a 3.7 kb &oRI fragment 
containing the apoC-II gene were purified by 
agarose gel ele~trophoresis and subcloned into the 
BamHI and EcoRI sites of pBR322, respectively. 
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Fig.1. Restriction map of the preproapoc-II gene. The four exons are indicated by the solid bars. The strategy for 
sequencing the preproapoc-II gene is illustrated by the horizontal arrows. Open circles indicate the use of synthetic 
oligonucleotides as primers for sequencing. Only enzymes used to generate fragments for sequencing are indicated. 
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One recombinant of each was then used for subse- 
quent restriction enzyme and sequence analysis. 
Fig. 1 illustrates the restriction endonuclease 
cleavage map and sequence analysis strategy of the 
apoC-II genomic clones. A combination of the 
Maxam and Gilbert [16] and Sanger et al. [17] se- 
quencing procedures was utilized. 
The complete nucleotide sequence of the 
preproapoc-II is shown in fig.2. A total of 3840 
nucleotides were sequeneed including the entire 
apoC-II gene, 200 bp in the 5 ’ -flanking region and 
273 bp in the 3 ’ -flanking region. The apoC-II gene 
is composed of 4 exons interrupted by 3 introns. 
All 3 introns begin and end with the dinucleotides 
GT and AG, respectively, and conform to the con- 
sensus sequence around exon-intron splice junc- 
tions 1191. Primer extension studies established 
that the 5’untranslated region of apoC-II mRNA 
consists of 38 bp and contains a guanine residue at 
the mRNA start site (nucleotide no.230) which is 
the second most commonly reported nucleotide at 
the mRNA start site [ 191. Thirty bases upstream 
from this guanine residue is a typical Goldberg- 
Hogness box [19] at nucleotides 200-206. Another 
putative promoter region, the CAAT-box, has 
been detected in several eukaryotic genes 70-80 bp 
upstre~ from the mRNA start site ]19,20]. In the 
apoC-II gene, however, we were unable to identify 
CUT-box-like sequences 200 nucleotides 
upstream from the TATA box. 
The first exon consists of 25 nucleotides, is 
30 bp downstream from a typical TATA box struc- 
ture, and encodes most of the 5 ‘-untranslated 
region of apoC-II mRNA. It is followed by an 
unusually long first intron which contains 2391 bp 
and 4 Alu type repetitive sequences which are 
labelled Alu l-4 in fig.2. Alu sequences are also 
present in the intervening sequences of other 
apolipoprotein genes including apoA-II [14,21], 
apoC-III [22] and apoE [23,24]. The significance 
of the Alu repeats found within mammalian genes 
is unclear, but it has been suggested that they may 
play a role in DNA replication or gene regulation 
1251. We have also identified a 22 dinucleotide se- 
quence of GT repeats followed by a 7 dinucleotide 
sequence of GA repeats between nucleotides 372 
and 429 of the first intron. A similar region of CT 
repeats is present in the second intron of the apoA- 
II gene [14]. GT repeats are fairly abundant in the 
mammalian genome 1261, and it has been suggested 
that these sequences may be associated with an in- 
creased frequency of recombination [27]. Fig.3 is 
an autoradiograph of the sequencing gel of the 
DNA strand complement~y to this GT-repeat se- 
quence. 
The second exon of the apoC-II gene is 68 bp 
long and encodes the rest of the 5 ‘-untranslated 
region of the apoC-II mRNA and amino acid - 28 
(methionine) to - 11 (phenyl~~ine) of the signal 
peptide. The second and third exons are inter- 
rupted by the second intron which consists of 
167 bp and interrupts the codon for amino acid 
- 11 of the signal peptide. The third (160 bp) and 
fourth (229 bp) exons encode amino acids - 10 
(Glu) to + 44 (Arg) and amino acids + 45 (Asp) to 
the polyadenylation site at the 3’-end of the apoC- 
II gene, respectively. The third intron is 298 bp 
long and contains a 38 bp long sequence that is 
repeated 6 times within the intron between 
nucleotides 3091 and 3312, suggesting that duplica- 
tion of this region of the apoC-II gene occurred 
at some point during evolution. Nucleotides 
3220-3262 of this repeat sequence show 90% 
homology with nucleotides 424 to 471 of the 
5’-flanking region of the apoE gene 1231. 
A comparison of the complete preproapoc-II 
genomic sequence obtained from our human 
placental library (shown in fig.1) and our white 
blood cell library reveals 4 base differences be- 
tween them. These include the deletion of a T and 
a G at positions 63 and 858, and the insertion of 
AA at position 1347 within intron 1 as shown in 
fig. 1. However, we identified 150 separate 
nucleotide differences from the previously pub- 
lished apoC-II sequence of Wei et al. [13] which 
was determined from a human peripheral blood 
lymphocytes genomic library. These differences 
are ihustrated in fig.2. Most of the base changes 
are located within the first intron or the 3 ‘-un- 
translated region of the gene whereas no dif- 
ferences were found in the exons. Major 
differences include a 22 versus an 8 dinucleotide se- 
quence of GT repeats between bp 372 and 414 of 
our sequence (see fig.3) and the presence of an ex- 
tra SstI restriction enzyme site at position 
2539-2544 within the 1st intron of the apoC-II 
gene. The reason for the variability of the apoC-II 
sequence from different genomic libraries is 
unclear at this time. 
We believe that the availability of genomic and 
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**CCC+QCCTCTaTC*8A0a 
OBaea*C%TC*ft*CtCTrT 
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aC*aa**ITT7**a*aa~**C 
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.....s11.1”.*** 
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BISEAIGPIXGLAIIIEEkG 
EEAAAAIIGEGEPAIGBGkE 
IIBGITPTOTTCITTCTCCO 
ITIOIOCCCTO~OC*TkTTC 
*CITOI*OTCTOLCIT1QB* 
CTCCCTi3CLETQ*CZSCeEC 
I&**I*OCEftCrlOOCTOC 
ror.cc$pHwmcc:o*c 
J;AISfiI&IZIEAlSEEISXA 
GCPIGGEEAAEA;GGIGkkk 
IkGEkCIIIGGQAQGGGAkG 
IEIkGIkkkkkIAGkkkkIk 
&IIPEfkP&4EEEI%SAPSE 
IEEkIEIChAAkAAIkEGkk 
EAQB~SAAIIGPXISAkEEI 
SISkSkIIEEAIEI~kkkkk 
:*aa:C:**C**OaaaaCTa 
EBA*TTCTC*e*OTa*EOQT 
CrafCtEE*CCC*fCCCCrC 
a8**QTOaGTCTO**CC*C~ 
**aao*c~c*aaoTacaaaa 
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TCT~C,T*e*BTT*%*Q1@* 
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SGIGbAAtEBGAIEIAl4GL 
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IIAGZEkB9kSPEISAGGEA 
IGEAGEEIBBGEGAGAGAA~ 
Gaa*y*a*TCTO*OCCfCT 
1. 
TTCOIC*CC***IaTOCC,C 
O*O*OCCCTI*QOT**C*C* 
TT*0E***OBsC*0*00CTT 
a~Tc*cTaacTc*c*ccToT 
CAQOcfaaaC**C****C** 
AIfGEABGAEII +$S,;GfiC 
EEEGAIGIEIkGIAAAAAIA 
QIGGQGGPkIEAESAGG3Gk 
IIAGEEQ9SEkI9GXG9EAG 
Aii$fiS;I9fW@AfiGG$AS 
AA~~~~~~I'AB'GGGG'GP 
GGGAGBIQBGGGIIGGAGfG 
~GAAAAkAkIkklkA~lAAk 
TOTCC**QICC*TaC*Taak 
GQGAQGt6GdBGEGBQIQGA 
kAkAAIAf4bkkAI~~P~EE 
IIQkAGCEAGGAAQfBGAGQ 
EIIQP f#SAAhAAk~GkkIS 
EEkkkEGEII~GBGkGSEEk 
EGSIEIEIkfIkkkkkfkEk 
SPkSkkIEPEXC~kkEELSS 
AABkEEIIBIGI~fifPAkkA 
TTCTaCCOT*CITCCIC*TC 
EkkBGGAGGPAkkItkGILG 
EkkAkklEAGGIQQGBEACk 
QkkBIIEGAGkEEASGGtSG 
SIGEIISIfiAXIEEkSEIEE 
kkfkPPEGkEfGfkGIEEkS 
IGGEPGGfGGEfGIkAEEEE 
kQEE~4GAIIQCAECkCISE 
AISI 
m 
~AAAlGAfi?kG,*a* 
***C,,OACTaak*E*CCa* 
ECOcCTCC**TE*O:CTaCC 
IEAEIIQABQICAGSAGIIE 
OPa~aIaaIks~4~d~ac~I 
IIGEASIGAQEEfk9AI~GI 
Ak&AkkIIIkkkkAAEIkkk 
4% 
6GGEkkkEGSkEGAEIIGkf 
AAAkIIkGkGkGGPklGG;G 
AASAEASkGGI~GCG9IQAP 
AAAkkkGkkIISI~GAPEkf 
YtCf*CaTaTaQ*Ta*ta*f 
AGGIIkBBkGITGA4GAGEA 
GIGGCIEkASEEISlAAIEE 
GGA~G~IPPXSAAAEG~AIG 
IIPO4k4 !#~kMiEAPAkBk 
GCtBGPIPkEkSkfiE~AijAt 
ASEIAEIPGSGkGGGIGAGS 
AELECkQEEIBSSPAkEkQk 
*TC*C*a**TQTTQa***aT 
l 13* e 
OCTE*C*C*a*aC*:***C, 
Fig.2. Complete nu~l~ti~ sequence of the prepraapoC-II gene. TATA-box and ~oi~aden~~~on signals are boxed. 
Exons are underlined and numbered. Alu sequences are underfined by an inte~~t~ line and numbered. The beginning 
and end of the (j-times repeated sequences within intron III are indicated by vertical bars and numbered. The 6 bp of 
the core enhancer sequence and the 42 bp homologous to the apoE 5’-flanking sequence are both underlined with 
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Fig.3. Autoradiograph of the sequencing el of the DNA 
strand complementary to the GT-GA repeat sequence 
within the first intron. Twenty-two dinucleotide GT 
repeats and 7 dinucleotide GA repeats are illustrated. 
Sequencing was performed by the dideoxynucleotide 
chain termination method of Sanger. 
cDNA clones of preproapoC:dI will permit the in- 
vestigation of the molecular m~h~isms involved 
in the regulation of apoC-II biosynthesis. In addi- 
tion, the complete genomic sequence of normal 
preproapoc-II will provide the basis for 
understanding the underlying defects in patients 
with apoC-II deficiency and other dyslipopro- 
teinemias. 
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